99mTc-MIBI imaging in prediction and evaluation the efficacy of neoadjuvant chemotherapy for osteosarcoma

Caixia Wu,Qian Wang,Yuan Li

2018-01-01

Abstract:132 Purpose: To investigate the double value of 99mTc-MIBI imaging in predicting and evaluating the response to preoperative chemotherapy in patients with osteosarcoma. Materials and method: Thirty-nine patients with osteosarcoma underwent 99mTc-MIBI imaging before chemotherapy were included in the study(31 males and 8 females; mean age: 16.1±8.3years). Of them, a repeated examination was performed in 27 patients after the completion of chemotherapy. Early and delayed planar images were obtained at 15min and 90 min respectively after the injection of 99mTc-MIBI. And the ratio of the tumor to background (T/B value) and the rate of washing out (WR) of MIBI were measured and calculated for each examination. Tumor response to chemotherapy was evaluated based on the necrosis rate of tumor tissues surgically removed after chemotherapy, which was defined as good response when the necrosis was ≥90%, and poor response when the necrosis was <90%. In contrast with the tumor necrosis rate, the significance of MIBI imaging for prediction of tumor response to chemotherapy was assessed on pre-chemotherapy images with the WR, while for evaluation of tumor response, on both pre-and post-chemotherapy images with the change ratio of T/B value. Results: Among the 39 patients who underwent pre-chemotherapy MIBI imaging, there were 15 patients with a good response to chemotherapy and 24 with poor response. Between the two groups of patients, no statistical difference was found on T/B values on both early images and delayed images, but the WR in patients with good response was significantly lower than those with poor response. Tumor washout rate of MIBI was correlated negatively with the tumor necrosis rate (r=-0.379,P=0.017). ROC analysis showed when a tumor WR≤24.5%was taken as the threshold for predicting good tumor response, a sensitivity of 95.8%, specificity of 73.3%and accuracy of 87.2% will be yielded. In the 27 patients who underwent both pre-and post-chemotherapy MIBI imaging,11 patients were defined as good response and 16 patients as poor response. On post-chemotherapy imaging, T/B values both on early and delayed images were significantly lower in the patients with good response compared with those with poor response(early imaging: t=3.712,P